Virtu Financial LLC Spectrum Pharmaceuticals Inc Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.65 - $1.31 $60,706 - $122,346	93,394 Added 144.77%	157,908 $152,000
Q1 2023 May 01, 2023	BUY	$0.38 - $1.07 $24,515 - $69,029	64,514 New	64,514 $48,000
Q2 2022 Aug 09, 2022	BUY	$0.7 - $1.4 $43,092 - $86,185	61,561 New	61,561 $48,000
Q4 2021 Feb 17, 2022	SELL	$1.27 - $2.42 $127,341 - $242,650	-100,269 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.82 $215,578 - $383,027	100,269 New	100,269 $219,000
Q1 2021 May 19, 2021	SELL	$2.9 - $4.09 $174,055 - $245,477	-60,019 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$3.38 - $5.14 $202,864 - $308,497	60,019 New	60,019 $205,000
Q2 2018 Jul 30, 2018	SELL	$14.31 - $21.75 $149,768 - $227,635	-10,466 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$14.31 - $21.75 $106,466 - $161,820	-7,440 Reduced 41.55%	10,466 $219,000
Q1 2018 May 14, 2018	BUY	$16.09 - $23.07 $288,107 - $413,091	17,906 New	17,906 $288,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.